ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT03574571

Public ClinicalTrials.gov record NCT03574571. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 8:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Study identification

NCT ID
NCT03574571
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Memorial Sloan Kettering Cancer Center
Other
Enrollment
732 participants

Conditions and interventions

Interventions

  • Docetaxel 60 mg/m2 Drug
  • Docetaxel 75 mg/m2 Drug
  • Radium-223 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 18, 2018
Primary completion
Mar 31, 2027
Completion
Mar 31, 2027
Last update posted
Feb 26, 2026

2018 – 2027

United States locations

U.S. sites
40
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
Banner MD Anderson Cancer Center Gilbert Arizona 85234
Yale University- Yale Cancer Center New Haven Connecticut 06510
Helen Graham Cancer Center (Christiana Care) Newark Delaware 19713
Boca Raton Regional Hospital Boca Raton Florida 33486
Mount Sinai Medical Center (Miami) Miami Florida 33140
Rush University Medical Center Chicago Illinois 606012
Indiana University Indianapolis Indiana 46202
Ochsner Cancer Institute New Orleans Louisiana 70121
University of Maryland Medical Center Baltimore Maryland 21201
University of Massachusetts Worcester Massachusetts 01655
University of Michigan Cancer Center Ann Arbor Michigan 48109
University of Minnesota Minneapolis Minnesota 55455
Nebraska Cancer Specialists Omaha Nebraska 68114
XCancer Omaha / Urology Cancer Center Omaha Nebraska 68130
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89128
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920
MD Anderson Cancer Center at Cooper Camden New Jersey 08103
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748
Memorial Sloan Kettering Bergen Montvale New Jersey 07645
New Jersey Urology Saddle Brook New Jersey 07663
New Mexico Oncology and Hematology Albuquerque New Mexico 87109
University of Buffalo Buffalo New York 14203
Roswell Park Cancer Institute Buffalo New York 14263-0001
Memorial Sloan Kettering Commack Commack New York 11725
Memorial Sloan Kettering Westchester Harrison New York 10604
Memorial Sloan Kettering Cancer Center New York New York 10065
New York Presbyterian Hospital-Weill Medical College of Cornell University New York New York 10065
Bronx VA Hospital New York New York 10468
University of Rochester Medical Center Rochester New York 14642
Memorial Sloan Kettering Nassau Uniondale New York 11553
University of North Carolina Chapel Hill North Carolina 27514
Atrium Health/ Levine Cancer Institute Monroe North Carolina 28112
University of Cincinnati Medical Center Cincinnati Ohio 45219
Dayton Physicians Network Kettering Ohio 45409
University of Oklahoma Oklahoma City Oklahoma 73104
MidLantic Urology Bala-Cynwyd Pennsylvania 19004
Medical University of South Carolina Charleston South Carolina 29425
Houston Methodist Research Institute Houston Texas 77030
Millennium Physicians Houston Texas 77090
University of Washington Seattle Washington 98109

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03574571, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03574571 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →